Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis

Saved in:

Bibliographic Details
Published in:	Neurology Vol. 50; no. 5; pp. 1266 - 1272
Main Authors:	RUDICK, R. A, SIMONIAN, N. A, MASS, M. K, RICHERT, J. R, SALAZAR, A. M, MUNSCHBAUER, F. E, COOKFAIR, D. L, SIMON, J. H, JACOBS, L. D, ALAM, J. A, CAMPION, M, SCARAMUCCI, J. O, JONES, W, COATS, M. E, GOODKIN, D. E, WEINSTOCK-GUTTMAN, B, HERNDON, R. M
Format:	Journal Article
Language:	English
Published:	Hagerstown, MD Lippincott Williams & Wilkins 01-05-1998
Subjects:	Biological and medical sciences Drug toxicity and drugs side effects treatment Medical sciences Pharmacology. Drug treatments Toxicity: blood Phase III trial Human Nervous system diseases Chemotherapy Multiple sclerosis Antibody Toxicity Central nervous system disease Exploration Serum Inflammatory disease
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	0028-3878 1526-632X
DOI:	10.1212/wnl.50.5.1266